 |
| A service of the U.S. National Institutes of Health |
New clinical trial for TNBC to start recruiting February 2013
http://clinicaltrials.gov/show/NCT01790932
(Click to link)
Purpose
This research study is a Phase II clinical trial. Phase II clinical trials test the effectiveness of an investigational drug to learn whether the drug works in treating a specific cancer. "Investigational" means that the drug is still being studied and that research doctors are trying to find out more about it-such as the safest dose to use, the side effects it may cause, and if the drug is effective for treating different types of cancer. It also means that the FDA has not yet approved BKM120 for use in patients, including people with your type of cancer.
BKM120 is a drug that works by blocking a protein called PI3K which may contribute to cancer growth. This drug has been used in experiments in the laboratory and information from these research studies suggests that BKM120 may help to prevent cancer cells from growing.
In this research study, the investigators are looking to see if BKM120 works to stop breast cancer cells from growing.